Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1376339/000137633916000213/mdxg-2016930x10xq.htm
• | Q3 2016 revenue of $64.4 Million is a 31% increase over Q3 2015 revenue |
• | Q3 2016 revenue exceeds $64.0 Million upper end of guidance |
• | Q3 2016 revenue beats analysts’ consensus estimates of $63.1 Million |
• | Revenue for nine months ended September 30, 2016 is a 29% increase over same 2015 period |
• | Adjusted Gross Margin* of 88.0% |
• | Adjusted EBITDA* of $11.4 million |
• | Adjusted Net Income* of $6.2 million |
• | Adjusted Diluted Net Income Per Share* of $0.06 |
• | Wound Care revenue of $49.8 million |
• | Surgical, Sports Medicine and Orthopedics (SSO) Revenue of $14.6 million |
• | Current direct sales force grows to nearly 300 sales professionals |
• | Gross margin of 87.6% |
• | Net Income of $3.3 million |
• | Diluted Net Income per share of $0.03 |
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Mimedx Group, Inc..
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1376339/000137633916000213/mdxg-2016930x10xq.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years